German private hospital operator running acute-care hospitals and university-affiliated clinics, majority owned by Asklepios.
German private hospital operator running acute-care hospitals and university-affiliated clinics, majority owned by Asklepios.
Paid per patient case under Germany's flat-rate system, set by insurers and state hospital planning, so margins depend on keeping costs under the fixed fees and filling beds. Governments pay for buildings and equipment; insurers pay running costs. The university hospital in Giessen and Marburg is a major site.
In one line: A German HCA Healthcare, smaller scale.
Moat: narrow (regulatory licence, scale, installed base). Licensed hospital capacity and academic-medicine partnerships, but reimbursement rates are government-regulated.
Headquarters: Bad Neustadt an der Saale, Germany · Founded: 1973 · Employees: 19,128
Size Rhon-klinikum (RHK.DE) is a Germany Health Care company (Hospital/Nursing Management) with a market value of $1.06B, the 138th largest of 198 Germany companies the cockpit tracks. Shares closed at €14.40 on 18 Nov 2026.
Performance Over six months the shares gained 15.2%, against -3.8% for the median peer and -0.9% for the Germany market (cap-weighted) — 5th highest of 20 in its peer set.
Growth Revenue grew 3.5% over the last twelve months (peer median +14.8%); the operating margin is -51.3% (peer median 10.8%).
Valuation It trades at 22.5× forward earnings against a peer median of 40.4× (4th cheapest of 16).
Capital Return on invested capital runs 51.5 points below its cost of capital (5.0% WACC).
Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €1.75B | €1.94B | €1.83B | €1.67B | €1.63B |
| Revenue growth | — | +6% | +9% | +2% | — |
| Gross profit | n/a | €168M | €171M | €136M | €160M |
| EBITDA | n/a | €69.4M | €69.0M | €45.7M | €88.3M |
| Net income | €42.4M | €34.5M | €43.4M | €38.7M | €25.1M |
| Free cash flow | n/a | -€34.6M | €68.3M | €56.7M | -€15.7M |
| Capital expenditure | n/a | €99.1M | €70.4M | €62.8M | €58.2M |
| Total debt | n/a | €122M | €150M | €150M | €158M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Rhon-klinikum RHK.DE | $1.06B | +15% | +4% | -51% | 22.5× | n/a |
| Fresenius SE & Co. KGaA FRE.DE | $32.7B | +41% | +7% | 10% | 14.7× | 7.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | RHK.DE | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.7% | +1.8% | 3rd lowest of 20 |
| 6-month return | +15.2% | -3.8% | 5th highest of 20 |
| Distance from 52-week high | -8.3% | -18.4% | 5th highest of 21 |
| Revenue growth (TTM) | +3.5% | +14.8% | 6th lowest of 21 |
| Operating margin | -51.3% | 10.8% | lowest of 21 |
| Forward P/E | 22.5× | 40.4× | 4th cheapest of 16 |
| ROIC minus cost of capital | -51.5 pp | -2.2 pp | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 49.4× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | n/a | 6.1% | +6.0% |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | n/a | n/a | n/a |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 88.8× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | n/a | 21.2% | +11.8% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 14.6× | 14.2% | +6.9% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 27.1× | -2.7% | +6.1% |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $759M | +22% | +17% | 21% | n/a | 17.4% | +18.1% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Artemis Medicare Services ARTEMISMED.NS | India | $582M | +25% | +15% | 13% | 42.3× | 48.5% | +21.5% |